Positive early results of extended-range IOL reported
LONDON — Early positive experience with the Tecnis Symfony IOL, which received CE mark in Europe earlier this year, was related in a press briefing hosted by Abbott Medical Optics here.
“Patients demand high-quality vision for a longer time, and they also demand vision that is spectacle-independent, which is crisp, clear and has no side effects,” Gerd U. Auffarth, MD, PhD, said during the briefing at the European Society of Cataract and Refractive Surgeons Congress.
Gerd U. Auffarth
Auffarth reported 1-month results from a 3-month, open-label, prospective, bilateral, multicenter study of outcomes in 82 patients implanted with the Symfony extended-range-of-vision IOL.
Ninety percent achieved 20/20 vision for far and intermediate distance acuities, and almost 90% achieved 20/40 or better for near visual acuity, according to Auffarth.
The 1-month data demonstrate extended range of vision with excellent uncorrected visual acuity for far and intermediate, and functional near vision, Auffarth said.
Additionally, there is a low incidence of optical symptoms, a high degree of patient satisfaction and spectacle independence, and no unexpected medical findings or device-related adverse effects, according to Auffarth.
Disclosure: Auffarth has received research grants from several IOL companies.